A first exon termination checkpoint preferentially suppresses extragenic transcription

  • Nat Struct Mol Biol. 2021 Apr;28(4):337-346. doi: 10.1038/s41594-021-00572-y.
Liv M I Austenaa  #  1 Viviana Piccolo  #  2 Marta Russo  #  2 Elena Prosperini  2 Sara Polletti  2 Danilo Polizzese  2 Serena Ghisletti  2 Iros Barozzi  3 Giuseppe R Diaferia  2 Gioacchino Natoli  4  5
Affiliations
  • 1. European Institute of Oncology (IEO) IRCCS, Milan, Italy. [email protected].
  • 2. European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  • 3. Department of Surgery and Cancer, Imperial College London, London, UK.
  • 4. European Institute of Oncology (IEO) IRCCS, Milan, Italy. [email protected].
  • 5. Humanitas University (Hunimed), Milan, Italy. [email protected].
  • # Contributed equally.
Abstract

Interactions between the splicing machinery and RNA polymerase II increase protein-coding gene transcription. Similarly, exons and splicing signals of enhancer-generated long noncoding RNAs (elncRNAs) augment enhancer activity. However, elncRNAs are inefficiently spliced, suggesting that, compared with protein-coding genes, they contain qualitatively different exons with a limited ability to drive splicing. We show here that the inefficiently spliced first exons of elncRNAs as well as promoter-antisense long noncoding RNAs (pa-lncRNAs) in human and mouse cells trigger a transcription termination checkpoint that requires WDR82, an RNA polymerase II-binding protein, and its RNA-binding partner of previously unknown function, ZC3H4. We propose that the first exons of elncRNAs and pa-lncRNAs are an intrinsic component of a regulatory mechanism that, on the one hand, maximizes the activity of these cis-regulatory elements by recruiting the splicing machinery and, on the Other, contains elements that suppress pervasive extragenic transcription.